Related Experiment Video
Updated: Feb 3, 2026

The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Comorbidity Remission Following Intragastric Dual Balloon Placement
Luis Garcia1, Sean Vajanaphanich1, John M Morton2
1Stanford University School of Medicine, 300 Pasteur Drive, H3680, Stanford, CA, 94305, USA.
Abstract:
The intragastric dual balloon was FDA approved in 2015 for the treatment of obesity. The objective of this study was to report the weight loss, comorbidity remission, and biochemical improvements experienced by 28 patients following intragastric dual balloon placement at a single institution between September 2015 and June 2017. Demographic data were collected preoperatively. Anthropometric, clinical, and biochemical data were collected preoperatively and 3 and 6 months postoperatively. Two patients were lost to data follow-up. Participants experienced significant improvements in blood pressure and lipid profiles, in addition to substantial weight loss 6 months after balloon insertion. The results of this study underscore the promise of the intragastric dual balloon as an efficacious intervention for weight loss and comorbidity remission in patients with early-stage obesity.
More Related Videos
Related Concept Videos
Dual Nature of Electromagnetic (EM) Radiation
Wavelength is the distance between two consecutive peaks (the highest point) or troughs (the lowest point) in the wave. Frequency is the number of...
Applications of the Ideal Gas Law: Molar Mass, Density, and Volume
Gas Laws: Boyle's, Gay-Lussac, Charles', Avogadro's, and Ideal Gas Law
VSEPR Theory and the Basic Shapes
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion
Classifying Matter by State

